Aerospace & Defense
Rocket Lab's Q2 FY2026 revenue surged 62% on strong space systems growth and net loss narrowed, with backlog hitting a record $2.4 billion, but the pending $8 billion Iridium acquisition creates significant uncertainty.
Key risk: Iridium Transaction Conditions May Not Be Satisfied
The completion of the Iridium acquisition is subject to numerous conditions, including stockholder approval, regulatory approvals, and no material adverse effects. Failure to satisfy these could delay or prevent the deal, potentially causing Rocket Lab to miss expected benefits.